649 related articles for article (PubMed ID: 19559406)
1. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
2. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
4. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK
Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991
[TBL] [Abstract][Full Text] [Related]
5. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS
Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Yang M; Nishio M
Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
[TBL] [Abstract][Full Text] [Related]
7. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
8. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
9. Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.
Meuillet EJ; Kroes R; Yamamoto H; Warner TG; Ferrari J; Mania-Farnell B; George D; Rebbaa A; Moskal JR; Bremer EG
Cancer Res; 1999 Jan; 59(1):234-40. PubMed ID: 9892212
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.
Liu Y; Su Y; Wiznitzer M; Epifano O; Ladisch S
Glycobiology; 2008 Aug; 18(8):593-601. PubMed ID: 18480157
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
12. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
Zolfaghari A; Djakiew D
Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
[TBL] [Abstract][Full Text] [Related]
15. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
[TBL] [Abstract][Full Text] [Related]
16. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
17. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor.
Yoshida J; Ishibashi T; Nishio M
Cancer Res; 2001 Aug; 61(16):6151-7. PubMed ID: 11507066
[TBL] [Abstract][Full Text] [Related]
18. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
Tysnes BB; Haugland HK; Bjerkvig R
Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]